annual CAPEX:
$33.00K(NaN%)Summary
- As of today (July 1, 2025), AKBA annual capital expenditures is $33.00 thousand
- During the last 3 years, AKBA annual CAPEX has fallen by -$26.00 thousand (-44.07%).
- AKBA annual CAPEX is now -99.50% below its all-time high of $6.66 million, reached on December 31, 2019.
Performance
AKBA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$18.00K+$16.00K(+800.00%)Summary
- As of today (July 1, 2025), AKBA quarterly capital expenditures is $18.00 thousand, with the most recent change of +$16.00 thousand (+800.00%) on March 31, 2025.
- AKBA quarterly CAPEX is now -99.29% below its all-time high of $2.53 million, reached on September 30, 2019.
Performance
AKBA quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$51.00K+$18.00K(+54.55%)Summary
- As of today (July 1, 2025), AKBA TTM capital expenditures is $51.00 thousand, with the most recent change of +$18.00 thousand (+54.55%) on March 31, 2025.
- AKBA TTM CAPEX is now -99.30% below its all-time high of $7.26 million, reached on September 30, 2019.
Performance
AKBA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AKBA CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -44.1% | -84.2% | -55.3% |
| 5 y5 years | -99.5% | - | -98.2% |
AKBA CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -71.0% | at low | -37.9% | >+9999.0% | -55.3% | +75.9% |
| 5 y | 5-year | -99.5% | at low | -94.3% | +140.0% | -98.2% | +75.9% |
| alltime | all time | -99.5% | at low | -99.3% | +140.0% | -99.3% | +75.9% |
AKBA CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $18.00K(+800.0%) | $51.00K(+54.5%) |
| Dec 2024 | $33.00K(-71.1%) | $2000.00(0.0%) | $33.00K(+6.5%) |
| Sep 2024 | - | $2000.00(-93.1%) | $31.00K(+6.9%) |
| Jun 2024 | - | $29.00K(>+9900.0%) | $29.00K(-74.6%) |
| Dec 2022 | $114.00K(+93.2%) | $0.00(0.0%) | $114.00K(0.0%) |
| Sep 2022 | - | $0.00(0.0%) | $114.00K(0.0%) |
| Jun 2022 | - | $0.00(-100.0%) | $114.00K(0.0%) |
| Mar 2022 | - | $114.00K(>+9900.0%) | $114.00K(+93.2%) |
| Dec 2021 | $59.00K(-81.4%) | $0.00(0.0%) | $59.00K(-84.3%) |
| Sep 2021 | - | $0.00(0.0%) | $376.00K(+13.6%) |
| Jun 2021 | - | $0.00(-100.0%) | $331.00K(-12.0%) |
| Mar 2021 | - | $59.00K(-81.4%) | $376.00K(+18.6%) |
| Dec 2020 | $317.00K | $317.00K(-804.4%) | $317.00K(+44.1%) |
| Sep 2020 | - | -$45.00K(-200.0%) | $220.00K(-92.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $45.00K(-79.5%) | $2.79M(-58.0%) |
| Dec 2019 | $6.66M(+314.4%) | $220.00K(-91.3%) | $6.66M(-8.4%) |
| Sep 2019 | - | $2.53M(+27.9%) | $7.26M(+44.1%) |
| Jun 2019 | - | $1.98M(+2.6%) | $5.04M(+55.7%) |
| Mar 2019 | - | $1.93M(+132.3%) | $3.24M(+101.6%) |
| Dec 2018 | $1.61M(-1.0%) | $830.00K(+170.4%) | $1.61M(+31.0%) |
| Sep 2018 | - | $307.00K(+77.5%) | $1.23M(-19.1%) |
| Jun 2018 | - | $173.00K(-41.6%) | $1.52M(+1.7%) |
| Mar 2018 | - | $296.00K(-34.2%) | $1.49M(-8.1%) |
| Dec 2017 | $1.62M(-39.1%) | $450.00K(-24.6%) | $1.62M(+33.0%) |
| Sep 2017 | - | $597.00K(+303.4%) | $1.22M(+95.8%) |
| Jun 2017 | - | $148.00K(-65.3%) | $623.00K(+31.2%) |
| Mar 2017 | - | $427.00K(+789.6%) | $475.00K(+889.6%) |
| Dec 2016 | $2.66M | $48.00K | $48.00K |
FAQ
- What is Akebia Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Akebia Therapeutics?
- What is Akebia Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Akebia Therapeutics?
What is Akebia Therapeutics annual capital expenditures?
The current annual CAPEX of AKBA is $33.00K
What is the all time high annual CAPEX for Akebia Therapeutics?
Akebia Therapeutics all-time high annual capital expenditures is $6.66M
What is Akebia Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of AKBA is $18.00K
What is the all time high quarterly CAPEX for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly capital expenditures is $2.53M
What is Akebia Therapeutics TTM capital expenditures?
The current TTM CAPEX of AKBA is $51.00K
What is the all time high TTM CAPEX for Akebia Therapeutics?
Akebia Therapeutics all-time high TTM capital expenditures is $7.26M